To Optimize Radiotherapeutic Plans for Superior Tumor Coverage Predicts Malignant Glioma Prognosis and Normal Tissue Complication Probability.
Chun-Yuan KuoWei-Hsiu LiuYu-Ching ChouMing-Hsien LiJo-Ting TsaiDavid Yc HuangJang-Chun LinPublished in: Journal of clinical medicine (2022)
The TOMO system provided optimal therapeutic planning, reducing NTCP and achieving better coverage. Combined with the clinical results, our findings suggest that TOMO can make malignant glioma patients close to OARs achieve better disease control.